K
KoBioLabs
Engaged in patents and studies in various fields including microbiome analysis, probiotics, and microbiome treatment technology
About KoBioLabs
KoBioLabs operates in the biotechnology sector, focusing on the development of microbiome-based products that promote beneficial interactions between the human body and the environment. The company serves a diverse range of clients, including healthcare providers, environmental organizations, and consumers seeking health and wellness solutions. KoBioLabs leverages its expertise in microbiomes to create products that improve health outcomes and environmental sustainability. The business model revolves around research and development, product sales, and strategic partnerships. Revenue is generated through the sale of proprietary microbiome products and solutions, as well as through collaborations and licensing agreements. KoBioLabs is committed to providing a supportive environment for its employees, fostering creativity and passion, and ensuring high returns on investment for its stakeholders.
Source: Dealroom company dataAt a glance
- Founded
- 2014
- Headquarters
- Seoul, South Korea
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
E-mart
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about KoBioLabs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See KoBioLabs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.